1. Home
  2. OKYO vs HGBL Comparison

OKYO vs HGBL Comparison

Compare OKYO & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OKYO
  • HGBL
  • Stock Information
  • Founded
  • OKYO 2007
  • HGBL 1937
  • Country
  • OKYO United Kingdom
  • HGBL United States
  • Employees
  • OKYO N/A
  • HGBL N/A
  • Industry
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • HGBL Business Services
  • Sector
  • OKYO Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • OKYO Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • OKYO 77.9M
  • HGBL 66.7M
  • IPO Year
  • OKYO 2022
  • HGBL N/A
  • Fundamental
  • Price
  • OKYO $2.55
  • HGBL $1.47
  • Analyst Decision
  • OKYO Strong Buy
  • HGBL Strong Buy
  • Analyst Count
  • OKYO 1
  • HGBL 1
  • Target Price
  • OKYO $7.00
  • HGBL $4.00
  • AVG Volume (30 Days)
  • OKYO 197.8K
  • HGBL 114.0K
  • Earning Date
  • OKYO 07-18-2025
  • HGBL 11-06-2025
  • Dividend Yield
  • OKYO N/A
  • HGBL N/A
  • EPS Growth
  • OKYO N/A
  • HGBL N/A
  • EPS
  • OKYO N/A
  • HGBL 0.10
  • Revenue
  • OKYO N/A
  • HGBL $48,940,000.00
  • Revenue This Year
  • OKYO N/A
  • HGBL $20.86
  • Revenue Next Year
  • OKYO N/A
  • HGBL $4.61
  • P/E Ratio
  • OKYO N/A
  • HGBL $14.76
  • Revenue Growth
  • OKYO N/A
  • HGBL N/A
  • 52 Week Low
  • OKYO $0.90
  • HGBL $1.43
  • 52 Week High
  • OKYO $3.35
  • HGBL $2.39
  • Technical
  • Relative Strength Index (RSI)
  • OKYO 64.07
  • HGBL 29.27
  • Support Level
  • OKYO $2.11
  • HGBL $1.47
  • Resistance Level
  • OKYO $2.70
  • HGBL $1.54
  • Average True Range (ATR)
  • OKYO 0.17
  • HGBL 0.07
  • MACD
  • OKYO 0.07
  • HGBL 0.00
  • Stochastic Oscillator
  • OKYO 89.95
  • HGBL 18.52

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: